## BA: The Boeing Company - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.0% in mid entry zone (4.0-10.0%), top 2% cross-sectional ranking. Short-term MRS_5 (4.5%) confirms momentum alignment. Strong momentum (+4.5% 5-day acceleration). Outperforming sector by 6.9%. Caution: overbought RSI (74).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($217.77)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Boeing stock jumps nearly 5% as $2.7B Apache support contract, risk-on trade lift Dow**
- Source: ts2.tech | 20260102T174900 | Bullish | Relevance: 100%
- Boeing shares surged nearly 5% due to a new $2.7 billion Pentagon contract for Apache helicopter support and a broader "risk-on" trading sentiment. This gain helped the Dow Jones Industrial Average snap a four-session losing streak. Investors are now looking to upcoming U.S. jobs and inflation data for further market direction.

**2. Boeing Wins $8B Israel F-15 Deal: Defense ETFs to Watch for Gains**
- Source: The Globe and Mail | 20260102T150732 | Bullish | Relevance: 100%
- Boeing has secured an $8.6 billion contract from the Pentagon to supply 25 F-15IA fighter jets to the Israeli Air Force, with an option for 25 more. While this is a significant win for Boeing, investors may consider defense ETFs as a diversified alternative to individual Boeing stock due to the company's past struggles with profit margins in its defense unit. Several ETFs like XAR, ITA, and PPA offer exposure to Boeing alongside other defense contractors, providing a way to capitalize on increased global defense spending with reduced risk.

**3. Boeing Wins $8B Israel F-15 Deal: Defense ETFs to Watch for Gains**
- Source: The Globe and Mail | 20260102T144626 | Somewhat-Bullish | Relevance: 100%
- Boeing secured an $8.6 billion contract to provide Israel with advanced F-15IA fighter jets, a deal that strengthens its defense segment. However, due to Boeing's past financial struggles with other fixed-price contracts, defense-focused ETFs are suggested as a more diversified and potentially less volatile investment option for those seeking to capitalize on increasing global defense spending. The article highlights several defense ETFs, including XAR, ITA, and PPA, which include Boeing stock alongside other robust defense contractors.

**4. The bullish case for Boeing stock in 2026**
- Source: TradingView — Track All Markets | 20260102T130737 | Bullish | Relevance: 100%
- Boeing's stock has shown strong recovery, fueled by increased orders, improved financials, and analyst optimism. Analysts foresee continued growth in revenue and a return to profitability in 2026, with potential catalysts like a large Chinese order and the 777x program entering service. Technical analysis also suggests a positive outlook, with potential for the stock to surpass previous highs.

**5. Boeing stock today: Pentagon’s $2.7B Apache deal puts BA in focus heading into 2026**
- Source: ts2.tech | 20260101T163955 | Somewhat-Bullish | Relevance: 100%
- Boeing received a significant $2.7 billion contract from the Pentagon for Apache helicopter post-production support, boosting its defense segment as the company navigates challenges in commercial jet output. This deal is crucial for providing a stable revenue stream, with investors closely watching Boeing's cash flow progress and upcoming late-January results. The stock's near-term performance hinges on delivery momentum and production stability, with upcoming macro-economic data and the Federal Reserve meeting also expected to influence its trajectory.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $245 | $240 | +2% |
| 2025-12-12 | Citigroup | $265 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | main | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.10M) |
| Sells | 7 ($0.75M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (+1.1%)
- Blackrock Inc.: 6.8% (+2.7%)
- FMR, LLC: 5.8% (+16.1%)
- State Street Corpora: 4.6% (+0.3%)
- Newport Trust Compan: 3.8% (+2.5%)

### Key Risks

1. Valuation stretched: PEG 6.5x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 6.53 signals overvaluation risk, limited margin of safety. Institutional flow bearish (2 selling vs 8 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $178.4B |
| Beta | 1.18 |
| 52W Range | $128.88 - $242.69 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.53 |
| Forward P/E | 97.4 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 4.4% to 9.0% (+4.5% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 98th percentile. MRS_5 at 4.5% confirms short-term momentum alignment. AM_20 at 8.4% shows strong absolute momentum above own 20MA. Outperforming sector by 6.9pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.50), confirming momentum. RSI overbought at 74, risk of mean reversion. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.97% (CS: 98) | Strong |
| RSI_14 | 74.5 | Overbought |
| MACD Histogram | 1.50 | Bullish |
| vs SMA20 | 1.084x | Above |
| vs SMA50 | 1.123x | Above |
| vs SMA200 | 1.108x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $227.77
- **Stop Loss:** $217.77 (4.4% risk)
- **Target:** $242.77 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 144
- **Position Value:** $32,798.88
- **Portfolio %:** 32.80%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $-0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-2.38 | $-7.47 | -214.4% |
| 2025Q2 | $-1.27 | $-1.24 | +2.4% |
| 2025Q1 | $-1.30 | $-0.49 | +62.4% |
| 2024Q4 | $-3.78 | $-5.90 | -56.1% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*